About KLA Corporation
KLA Corporation (KLAC) is a Healthcare company in the Optical Instruments & Lenses industry with a market capitalisation of $199.3B. The stock trades at 38.00x trailing earnings and yields 0.55%.
- Sector
- Healthcare
- Industry
- Optical Instruments & Lenses
- Market cap
- $199.3B
- P/E ratio
- 38.00
- EPS (TTM)
- $3.66
- Revenue (TTM)
- $13.6B
- Free cash flow
- $3.8B
- Profit margin
- 35.6%
- Dividend yield
- 0.55%
- Shares outstanding
- 1.3B
Financial health: Strong9.5/10
9 strengths, 0 concerns. No red flags against these benchmarks.
- Debt to equity: 0.93 (Watch, benchmark < 0.5) — Debt of 0.93x equity is moderate against the 0.5x benchmark. It has improved over the last 4 years.
- Net debt vs cash flow: 1.1y (Strong, benchmark < 4 years) — Net debt of $4.2B is 1.1x annual free cash flow — about a year of cash flow to repay.
- Current ratio: 2.88 (Strong, benchmark > 1.5) — Short-term assets cover 2.88x short-term liabilities, against Graham's 1.5x floor. It has improved over the last 4 years.
- Return on equity: 76.1% (Strong, benchmark > 15%) — Earns 76.1% on shareholder equity, comfortably past the > 15% mark.
- Gross margin: 61.5% (Strong, benchmark > 40%) — Keeps 61.5% of revenue after the direct cost of sales, comfortably past the > 40% mark.
- Net margin: 35.6% (Strong, benchmark > 10%) — Turns 35.6% of revenue into profit, comfortably past the > 10% mark.
- Free cash flow: $3.8B (Strong, benchmark positive) — Generated $3.8B of free cash flow after capital spending. It has improved over the last 4 years.
- Revenue growth: 11.7% (Strong, benchmark > 10%) — Revenue changed 11.7% year on year, comfortably past the > 10% mark.
- Earnings growth: 18.9% (Strong, benchmark > 10%) — Earnings changed 18.9% year on year, comfortably past the > 10% mark.
- Payout ratio: 21.9% (Strong, benchmark < 60%) — Pays out 21.9% of earnings as dividends, leaving room to keep paying.